Skip to main content
Top
Published in: Medical Microbiology and Immunology 3/2003

01-08-2003 | Original Investigation

Virology and epidemiology of oral herpesvirus infections

Authors: Wolfgang Preiser, Hans Wilhelm Doerr, Jens-Uwe Vogel

Published in: Medical Microbiology and Immunology | Issue 3/2003

Login to get access

Excerpt

Herpesviruses are widely disseminated throughout the animal kingdom. The enveloped herpesvirus particles are pleomorphic with an overall diameter ranging from 120 to 300 nm. The virion consists of four structural elements as revealed by electron microscopy and illustrated in Fig. 1. Inside an electron-opaque core, there is the packaged linear double-stranded DNA genome with a molecular mass of between 80 and 150 million Daltons depending on the species.
Fig. 1.
Herpesvirus morphology. Left: Electron micrograph of a typical herpesvirus particle; right: schematic representation of herpes virion
Literature
1.
go back to reference Buxbaum S, Doerr HW, Allwin R (2001) Untersuchungen zur Immunitätslage der impfpräventablen Kinderkrankheiten Röteln, Masern, Mumps und Windpocken. Dtsch Med Wochenschr 126:1289–1293 Buxbaum S, Doerr HW, Allwin R (2001) Untersuchungen zur Immunitätslage der impfpräventablen Kinderkrankheiten Röteln, Masern, Mumps und Windpocken. Dtsch Med Wochenschr 126:1289–1293
2.
go back to reference Enzensberger R, Braun W, July C, Helm EB, Doerr HW (1991) Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection. Infection 19:140–145 Enzensberger R, Braun W, July C, Helm EB, Doerr HW (1991) Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection. Infection 19:140–145
3.
go back to reference Knipe DM, Howley PM (eds) (2001) Fields virology, vol 1 and 2, 4th edn. Lippincott, Williams & Wilkins, Philadelphia Knipe DM, Howley PM (eds) (2001) Fields virology, vol 1 and 2, 4th edn. Lippincott, Williams & Wilkins, Philadelphia
4.
go back to reference Preiser W, Szép N I, Lang D, Doerr HW, Rabenau HF (2001) Kaposi's sarcoma-associated herpesvirus seroprevalence in selected German patients: evaluation by different test systems. Med Microbiol Immunol 190:121–127 Preiser W, Szép N I, Lang D, Doerr HW, Rabenau HF (2001) Kaposi's sarcoma-associated herpesvirus seroprevalence in selected German patients: evaluation by different test systems. Med Microbiol Immunol 190:121–127
5.
go back to reference Rabenau HF, Buxbaum S, Preiser W, Weber B, Doerr HW (2002) Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol 190:153–160 Rabenau HF, Buxbaum S, Preiser W, Weber B, Doerr HW (2002) Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol 190:153–160
6.
go back to reference Vogel J-U, Weber B, Doerr HW (1994) Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent restriction fragment length polymorphism analysis. Zentralbl Bakteriol 281:502–512 Vogel J-U, Weber B, Doerr HW (1994) Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent restriction fragment length polymorphism analysis. Zentralbl Bakteriol 281:502–512
7.
go back to reference Wutzler P, Doerr HW, Färber I, Eichhorn U, Helbig B, Sauerbrei A, Brandstädt A, Rabenau HF (2000) Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relation and relevance for the incidence of herpes genitalis. J Med Virol 61:201–207 Wutzler P, Doerr HW, Färber I, Eichhorn U, Helbig B, Sauerbrei A, Brandstädt A, Rabenau HF (2000) Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relation and relevance for the incidence of herpes genitalis. J Med Virol 61:201–207
Metadata
Title
Virology and epidemiology of oral herpesvirus infections
Authors
Wolfgang Preiser
Hans Wilhelm Doerr
Jens-Uwe Vogel
Publication date
01-08-2003
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 3/2003
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-002-0127-0

Other articles of this Issue 3/2003

Medical Microbiology and Immunology 3/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.